Before joining NovaMedica within five years Ivan Daskal was responsible for legal support and control of compliance with the legislation in the Russian branch of Allergan where within the frameworks of the cross-functional tasks he developed and played the key role in implementing a number of significant local and regulatory acts of the company which referred to commercial and marketing activities, organized work aimed at struggle against counterfeit products circulation in the Russian market. Earlier Ivan headed legal function in the Diagnostic Department of Abbott Laboratories LLC (Russia), in Energomash JSC and Dirol Cadbury LLC.
Ivan graduated from the Yaroslav-the-Wise Novgorod State University, faculty of law.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024